Zobrazeno 1 - 2
of 2
pro vyhledávání: '"transforming growth factor‐β (TGF‐β)/Smad signalling pathway"'
Autor:
Changwei Liu, Li Ni, Xiaoxue Li, Hanyu Rao, Wenxin Feng, Yiwen Zhu, Wei Zhang, Chunxiao Ma, Yue Xu, Liming Gui, Ziyi Wang, Rebiguli Aji, Jin Xu, Wei‐Qiang Gao, Li Li
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 11, Pp n/a-n/a (2023)
Abstract Background Renal fibrosis is the final development pathway and the most common pathological manifestation of chronic kidney disease. Epigenetic alteration is a significant intrinsic factor contributing to the development of renal fibrosis. S
Externí odkaz:
https://doaj.org/article/48c69ae3f5cb4101a3dcd854056e605c
Autor:
Liu C; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Ni L; Department of Nursing, Shanghai East Hospital, Tongji University, Shanghai, China., Li X; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Rao H; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Feng W; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Zhu Y; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Zhang W; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Ma C; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Xu Y; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Gui L; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Wang Z; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Aji R; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Xu J; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Gao WQ; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Li L; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2023 Nov; Vol. 13 (11), pp. e1468.